vs
LEE ENTERPRISES, Inc（LEE）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
LEE ENTERPRISES, Inc的季度营收约是RIGEL PHARMACEUTICALS INC的1.9倍（$130.1M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -4.3%，领先388.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -10.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -5.8%）
李企业是一家上市美国传媒企业，在全美25个州运营着72份日报，同时还经营超过350份周报、分类广告刊物及各类专业刊物。公司由阿尔弗雷德·威尔逊·李于1890年创立，总部坐落于爱荷华州达文波特。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LEE vs RIGL — 直观对比
营收规模更大
LEE
是对方的1.9倍
$69.8M
营收增速更快
RIGL
高出31.2%
-10.0%
净利率更高
RIGL
高出388.4%
-4.3%
两年增速更快
RIGL
近两年复合增速
-5.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $130.1M | $69.8M |
| 净利润 | $-5.6M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 4.0% | 33.2% |
| 净利率 | -4.3% | 384.0% |
| 营收同比 | -10.0% | 21.2% |
| 净利润同比 | 66.5% | 1769.2% |
| 每股收益（稀释后） | $-0.92 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LEERIGL
| Q4 25 | $130.1M | $69.8M | ||
| Q3 25 | $139.1M | $69.5M | ||
| Q2 25 | $141.3M | $101.7M | ||
| Q1 25 | $137.4M | $53.3M | ||
| Q4 24 | $144.6M | $57.6M | ||
| Q3 24 | $158.6M | $55.3M | ||
| Q2 24 | $150.6M | $36.8M | ||
| Q1 24 | $146.6M | $29.5M |
净利润LEERIGL
| Q4 25 | $-5.6M | $268.1M | ||
| Q3 25 | $-6.4M | $27.9M | ||
| Q2 25 | $-1.9M | $59.6M | ||
| Q1 25 | $-12.5M | $11.4M | ||
| Q4 24 | $-16.7M | $14.3M | ||
| Q3 24 | $-10.1M | $12.4M | ||
| Q2 24 | $-4.3M | $-1.0M | ||
| Q1 24 | $-12.2M | $-8.2M |
毛利率LEERIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率LEERIGL
| Q4 25 | 4.0% | 33.2% | ||
| Q3 25 | -1.0% | 40.9% | ||
| Q2 25 | 3.3% | 60.1% | ||
| Q1 25 | -3.3% | 23.9% | ||
| Q4 24 | -2.3% | 28.9% | ||
| Q3 24 | -2.3% | 25.4% | ||
| Q2 24 | 3.3% | 1.2% | ||
| Q1 24 | -3.1% | -23.6% |
净利率LEERIGL
| Q4 25 | -4.3% | 384.0% | ||
| Q3 25 | -4.6% | 40.2% | ||
| Q2 25 | -1.4% | 58.6% | ||
| Q1 25 | -9.1% | 21.5% | ||
| Q4 24 | -11.6% | 24.9% | ||
| Q3 24 | -6.4% | 22.5% | ||
| Q2 24 | -2.8% | -2.8% | ||
| Q1 24 | -8.3% | -27.9% |
每股收益（稀释后）LEERIGL
| Q4 25 | $-0.92 | $14.11 | ||
| Q3 25 | $-1.02 | $1.46 | ||
| Q2 25 | $-0.31 | $3.28 | ||
| Q1 25 | $-2.07 | $0.63 | ||
| Q4 24 | $-2.80 | $0.82 | ||
| Q3 24 | $-1.68 | $0.70 | ||
| Q2 24 | $-0.73 | $-0.06 | ||
| Q1 24 | $-2.06 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.6M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-48.7M | $391.5M |
| 总资产 | $592.6M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LEERIGL
| Q4 25 | $12.6M | $155.0M | ||
| Q3 25 | $10.0M | $137.1M | ||
| Q2 25 | $14.1M | $108.4M | ||
| Q1 25 | $4.7M | $77.1M | ||
| Q4 24 | $6.1M | $77.3M | ||
| Q3 24 | $9.6M | $61.1M | ||
| Q2 24 | $13.4M | $49.1M | ||
| Q1 24 | $16.1M | $49.5M |
总债务LEERIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益LEERIGL
| Q4 25 | $-48.7M | $391.5M | ||
| Q3 25 | $-43.3M | $117.6M | ||
| Q2 25 | $-40.5M | $81.9M | ||
| Q1 25 | $-38.9M | $18.6M | ||
| Q4 24 | $-26.7M | $3.3M | ||
| Q3 24 | $-9.9M | $-14.6M | ||
| Q2 24 | $4.0M | $-29.9M | ||
| Q1 24 | $7.9M | $-31.7M |
总资产LEERIGL
| Q4 25 | $592.6M | $513.6M | ||
| Q3 25 | $601.7M | $242.5M | ||
| Q2 25 | $622.7M | $206.7M | ||
| Q1 25 | $623.9M | $176.0M | ||
| Q4 24 | $633.0M | $164.0M | ||
| Q3 24 | $649.2M | $139.4M | ||
| Q2 24 | $677.5M | $128.4M | ||
| Q1 24 | $684.8M | $126.5M |
负债/权益比LEERIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.5M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $3.7M | — |
| 自由现金流率自由现金流/营收 | 2.9% | — |
| 资本支出强度资本支出/营收 | 0.6% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $1.5M | — |
8季度趋势，按日历期对齐
经营现金流LEERIGL
| Q4 25 | $4.5M | $22.0M | ||
| Q3 25 | $-6.3M | $24.0M | ||
| Q2 25 | $8.9M | $30.5M | ||
| Q1 25 | $-790.0K | $-893.0K | ||
| Q4 24 | $-7.3M | $14.5M | ||
| Q3 24 | $-261.0K | $21.7M | ||
| Q2 24 | $-1.9M | $302.0K | ||
| Q1 24 | $3.2M | $-5.0M |
自由现金流LEERIGL
| Q4 25 | $3.7M | — | ||
| Q3 25 | $-8.3M | — | ||
| Q2 25 | $8.3M | — | ||
| Q1 25 | $-2.2M | — | ||
| Q4 24 | $-8.9M | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-5.5M | — | ||
| Q1 24 | $1.3M | — |
自由现金流率LEERIGL
| Q4 25 | 2.9% | — | ||
| Q3 25 | -6.0% | — | ||
| Q2 25 | 5.9% | — | ||
| Q1 25 | -1.6% | — | ||
| Q4 24 | -6.1% | — | ||
| Q3 24 | -1.8% | — | ||
| Q2 24 | -3.6% | — | ||
| Q1 24 | 0.9% | — |
资本支出强度LEERIGL
| Q4 25 | 0.6% | — | ||
| Q3 25 | 1.4% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 2.4% | — | ||
| Q1 24 | 1.3% | — |
现金转化率LEERIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LEE
| Advertising And Marketing Services | $60.0M | 46% |
| Subscription And Circulation | $57.7M | 44% |
| Other | $12.4M | 10% |
RIGL
暂无分部数据
